Philips has officially launched its ECG AI Marketplace, a secure platform that brings advanced artificial intelligence algorithms directly into the ECG workflow. The first certified third-party tool available on the marketplace is the Low Ejection Fraction (LEF) algorithm developed by Anumana AI. It's a Mayo Clinic spin-out focused on cardiovascular AI solutions.
The LEF algorithm is designed to detect signs of reduced ejection fraction from a standard 12-lead ECG. Traditionally, this condition is an early indicator of heart failure, could only be identified through echocardiography or advanced imaging. By embedding Anumana AI’s tool into the Philips ecosystem, clinicians can now flag high-risk patients earlier, without adding extra steps to their workflow.
Why this matters:
- Philips integration: The AI tool runs directly within Philips systems such as IntelliSpace ECG and PageWriter cardiographs, reducing IT complexity for hospitals.
- Clinical validation: Anumana’s algorithm has been tested in studies involving more than 150,000 patients and nearly 100 peer-reviewed publications.
- Impact on care: Earlier detection means faster referrals for imaging and treatment, helping clinicians address heart failure before symptoms become critical.
Philips positions the ECG AI Marketplace as a vendor-neutral hub, giving health systems a simple way to access certified algorithms without heavy integration projects. Anumana AI is the first partner, but more solutions are expected to join the marketplace in the future.
Heart Medical’s Perspective
As an authorized Philips Healthcare reseller, Heart Medical sees this development as directly relevant to our customers. We already support clinics and hospitals with Philips ECG systems, ultrasound machines, and cardiac accessories. The addition of AI tools through Philips’ marketplace strengthens the value of these devices, turning them into smarter platforms that can deliver earlier insights and improve outcomes.
For health systems, this means the investments made in Philips ECG technology today can be future-proofed with AI integration tomorrow. At Heart Medical, our role is to ensure customers not only receive the latest equipment but also stay informed about critical innovations like the Anumana AI partnership.
Looking Ahead
Philips’ ECG AI Marketplace is a milestone in the adoption of artificial intelligence in cardiology. For Heart Medical clients, it signals an ecosystem that is growing stronger, smarter, and more capable of meeting tomorrow’s challenges in cardiac care.
To learn more about Philips ECG systems and how AI integration can benefit your practice, contact Heart Medical today.
Reviewed by Heart Medical Clinical Applications Team
Clinical and technical specialists ensuring accuracy and relevance across all Heart Medical content.